Overview

TRACER RGD-K5 Carotid Plaque Imaging Study

Status:
Terminated
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the ability of the compound[F-18]RGD-K5, when used as a tracer during PET (positron emission tomography) imaging, to detect regions of unstable atherosclerotic plaque in the carotid artery of subjects being considered for carotid endarterectomy (CEA),and to confirm this ability through histological studies of samples of carotid artery plaques that will be collected during the planned carotid surgery.
Phase:
Phase 2
Details
Lead Sponsor:
Balaji Tamarappoo
The Cleveland Clinic